Synthesis, Characterization, Cellular Uptake, and In Vitro Anticancer Activity of Fullerenol-Doxorubicin Conjugates
Doxorubicin (DOX) is one of the most commonly used chemotherapeutic agents for treating human cancer. However, its clinical use has been limited by DOX-induced cardiotoxicity as well as other side effects. In the present study, we designed and synthesized the fullerenol (FU)-DOX conjugates and folic...
Saved in:
Main Authors: | Beihua Xu (Author), Li Yuan (Author), Ying Hu (Author), Zhiyuan Xu (Author), Jiang-Jiang Qin (Author), Xiang-Dong Cheng (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Terphenyllin Suppresses Orthotopic Pancreatic Tumor Growth and Prevents Metastasis in Mice
by: Jia Zhang, et al.
Published: (2020) -
Fullerenols in therapy and diagnosis of cancer
by: Anna Lichota, et al.
Published: (2016) -
Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy
by: Wen-Kai Yu, et al.
Published: (2020) -
Effect simultaneous delivery with P-glycoprotein inhibitor and nanoparticle administration of doxorubicin on cellular uptake and in vitro anticancer activity
by: Ozgur Esim, et al.
Published: (2020) -
Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance
by: Weihong Guo, et al.
Published: (2018)